Filing Details
- Accession Number:
- 0001214659-23-004146
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-23 16:30:12
- Reporting Period:
- 2023-03-22
- Accepted Time:
- 2023-03-23 16:30:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1677077 | Alzamend Neuro Inc. | ALZN | Pharmaceutical Preparations (2834) | 811822909 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1866270 | Fahey Lynne Mcgrath | 3480 Peachtree Road Ne Second Floor, Suite 103 Atlanta GA 30326 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-22 | 10,000 | $0.44 | 10,000 | No | 4 | P | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Spouse |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 75,000 | Direct |
Footnotes
- The shares were purchased in an individual retirement account owned by Mrs. McGrath's spouse. Mrs. McGrath disclaims beneficial ownership of the shares held by her spouse, and the inclusion of these shares shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.